Inside the Xingchen Bio conference room.

Everyone clenched their fists in excitement.

"That's fantastic! This will once again give our company a significant boost in global influence!"

"Yes, all 13 newly improved drugs have recently entered clinical trials. If they are launched on the market one after another, they will have more opportunities to compete with pharmaceutical companies in Europe and the United States!"

Su Chen looked straight ahead, and on the large screen in the conference room, the data reports were nodding in approval.

Although Xingchen Bio is not listed on the stock market, the stock of its subsidiary Fangyuan Pharmaceutical has already increased by more than 100 yuan per share.

The stock price has reached eight times its pre-IPO level.

All of this is thanks to the drugs developed by Xingchen Biotechnology.

The two companies are jointly profitable, with profits exceeding 20 billion yuan.

In order to support its development, the Chinese government has allocated a large amount of resources to Xingchen Bio after the establishment of the pharmaceutical alliance.

They truly give you money when you want money and people when you want people.

A steady stream of scientific research talents are working, primarily through Su Chen's company, towards the goal of integrating national pharmaceutical resources.

The goal is to use "reverse engineering R&D technology" to accelerate the improvement of more drug formulations.

It is used to significantly improve the cure rate of various diseases.

The advent of these technologies will accelerate the improvement of the overall medical level in China.

This is for a country with a large population.

This is definitely a major benefit for the people.

now.

Throughout China, the market share of large multinational pharmaceutical companies is shrinking rapidly.

It's only a matter of time before they are replaced by domestic Chinese pharmaceutical companies.

After the investigator finished his report, Su Chen turned to a director beside him and said:

"Director Li, how is the work you've been doing with the pharmaceutical alliance regarding the collection and organization of traditional Chinese medicine prescriptions?"

This Director Li, whose real name is Li Yixing, is the person in charge that Su Chen sent to the Medical Alliance.

He is also the director of the Traditional Chinese Medicine R&D Department of Xingchen Biotechnology.

He was a newly recruited pharmacology expert with outstanding professional skills, introduced by Qiao Huaiyuan.

Moreover, his expertise lies in the research of traditional Chinese medicine.

actually.

At the very beginning of the establishment of the entire medical alliance.

Of the two key areas for breakthrough, [the focus is on] identifying [the key areas].

One approach is to use Su Chen's new technology to accelerate the drug development process, with the aim of reducing costs, improving efficacy, and competing head-on with Western pharmaceutical companies.

The other is to develop and strengthen traditional Chinese medicine, a treasure of China.

If we can continuously optimize traditional Chinese medicine prescriptions and develop a set of methods for extracting effective components from Chinese medicinal materials, then we can achieve great results.

That would allow them to leapfrog ahead in a medical field that is completely inaccessible to Western countries.

However, traditional Chinese medicine is now in decline. The reason for this predicament is that traditional Chinese medicine lacks a complete and systematic drug research and development system.

If we can systematically optimize the medicinal ingredients, prescription mechanisms, and preparation methods of traditional Chinese medicine.

Perhaps one day in the future.

The development of traditional Chinese medicine may even surpass the current medical system.

When Su Chen asked, Li Yixing answered seriously:

"President Su, we have completed most of the compilation of prescriptions in the Chinese Materia Medica. Next, under the leadership of Academician Qiao, we will conduct research on the mechanisms of traditional Chinese medicine and the extraction of effective components."

"However, we still lack effective technical means for extracting the effective components of Chinese medicinal herbs. Academician Qiao said that if you, President Su, could personally participate in the research, it might help the entire team achieve a technological breakthrough."

After Li Yixing finished speaking, he looked at Su Chen with anticipation.

This person's research into the field of traditional Chinese medicine has reached the point of obsession.

He switched jobs from his previous research institute of traditional Chinese medicine to join Xingchen Biotechnology, entirely attracted by the strength of Xingchen Biotechnology and Su Chen.

In addition, Su Chen's position as vice chairman of the Medical Alliance will provide him with more platforms to showcase his abilities.

So when he was recommended to Su Chen by Qiao Huaiyuan.

Li Yixing agreed without hesitation.

Today, Xingchen Bio's R&D team has already exceeded 300 people!

This is also why they were able to develop more than a dozen blockbuster new drugs at the same time.

When Li Yixing asked, Su Chen suddenly realized that if he hadn't been too busy lately, he would have forgotten about his plan to enter the field of traditional Chinese medicine.

Su Chen no longer needs to worry too much about Xingchen Biotechnology.

Over the past month, he has also completed the technical and theoretical improvements to the ten drug formulas he collaborated on with the pharmaceutical alliance.

Next, it was handed over to the company's R&D team and the people from the pharmaceutical alliance to conduct laboratory-stage research.

Moreover, he had already planned to go to Beijing again.

After all, before returning from Ruidian, he and Xia Niannian had already agreed to visit his future father-in-law's house.

"Okay, Director Li, if you hadn't mentioned it, I would have completely forgotten about it. In that case, let's set off the day after tomorrow and make the most of our time to go to Tsinghua and Peking Universities again."

"After all, I need to prepare for my trip to Africa as soon as possible."

at the same time.

Inside the medical school office building in the United States.

A group of politicians, officials, and representatives from major multinational pharmaceutical companies sat around a huge conference table, all looking displeased.

An official wearing glasses, his brow furrowed, spoke in a reprimanding tone:

"Professor Eric, it was you who recommended Su Chen. If he hadn't won the Nobel Prize, how could his company and the drugs he developed have achieved such a high level of influence globally?"

Seeing this, a pharmaceutical company representative standing nearby also said sarcastically:

“Professor Eric, you must understand one thing: in the pharmaceutical field, our country aims to maintain a global monopoly. If we continue to allow that Chinese man named Su Chen to develop further, then in the future, you will be a sinner against our entire nation.”

At this point, another official from the medical department stated the purpose of the meeting:

“Professor Eric, you must take responsibility for this. We have already started collecting negative news about that company.”

"Also, regarding Su Chen's paper, I hope you will be in charge of writing a paper that questions the authenticity of his research. After all, his paper was published in a journal under our management, so this operation should not be too difficult for you."

"As for communicating with the Nobel Committee, we will also join forces with European countries to put pressure on them to report on the shady dealings surrounding Su Chen's Nobel Prize. In that case, it's not impossible for his Nobel Prize to be revoked."

"By the way, his company also has three drugs currently on the market globally. We will also find specialized researchers to analyze the serious side effects of those drugs."

"Of course, in the end, it will be up to you to lead the entire Harvard research team to conduct the analysis and evaluation."

"After all, in the entire medical field, the majority of people still trust our country and Harvard."